Notably, the Ranbir Kapoor-Sai Pallavi starrer 'Ramayana: Part One', which was released on November 5, today entered the ₹500 club, according to data provided by Sacnilk.
ZEEL settled with a bullish reversal candlestick pattern on its weekly charts, signalling a potential relief rally toward the 80 mark in the near term, show tech charts.
Divi's Labs, Laurus Labs, Sai Life Sciences and Glenmark Pharma quoted at their respective record highs in Monday's trade.
Sai Life Sciences' consolidated net profit increased by 17 per cent Y-o-Y to ₹98 crore in the September quarter of FY27. Its revenue grew by 23 per cent Y-o-Y to ₹659 crore.
MOFSL said it remains positive on Jubilant Food's medium-term outlook, supported by 5-7 per cent LFL growth potential, strong Popeyes momentum, and healthy international performance.
The Nifty PSU Bank index was the top gainer among sectoral indices up 2% in Monday's intraday deals, while the Nifty slipped 0.3%.
Analysts at Emkay retained 'Buy' rating on Voltas with a target price of ₹1,500 as valuations remain attractive and the stock trades near the lower end of the historical range.
The stock price of Divi's Labs quoted higher for the 12th straight trading day, surging 32 per cent during the period.
Tata Steel has posted a more than 16 per cent Y-o-Y rise in consolidated net profit to ₹3,700 crore in the September quarter, driven by higher revenues, mainly from India operations.
In 2026 so far, Honasa shares have climbed 70 per cent and are up 76 per cent on a one-year basis, according to NSE data.
Pharma stocks on a roll: Symbiotec Pharmalab, Windlas Biotech, Sai Life Sciences, Alembic Pharmaceuticals and Fermation Biotech were up in the range of 9-20% on Friday.
At 12:24 PM on Friday, the BSE Capital Goods index was the top loser among sectoral indices down 3.3 per cent, while the BSE Sensex gained 0.84 per cent.
Airtel stock now trades less than 3 per cent away from its all-time high of ₹2,174.50 touched on November 21, 2025.
ICICI Bank's market cap touched ₹10.96 trillion on the BSE in intraday trade on Friday, BSE data shows.
Sai Life Sciences continues to expect a stronger second half, supported by the progression of the development and commercial pipeline and the ramp-up of new capacity.
For the September quarter (Q2FY27), Mahindra & Mahindra has reported a 25 per cent rise in consolidated PAT to ₹4,587.88 crore, backed by strong revenue growth, particularly for the auto segment.
Thermax said quarterly profitability in the Industrial Product segment was impacted by product mix and higher input costs.
Titan Company's consolidated net profit in the second quarter of the ongoing financial year (Q2FY27) was up 113.7 per cent at ₹2,393 crore.
Nifty Bank index jumped 3.45 per cent to 57,847, with all index constituents in the green. Nifty Financial Services, meanwhile, zoomed 4.24 per cent to 26,667.
Nykaa reported an over 200 per cent rise in consolidated net profit to about ₹101 crore in the second quarter ended September 30, 2026.